Our blog

Biotech Funding Q4 2024
Biotech Funding Q4 2024
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout Q4 2024.
Read more
Biotech Funding Rounds and Key Findings | February
Biotech Funding Rounds and Key Findings | February
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry. In this blog, we explore the latest funding updates throughout the month of February.
Read more
Hiring Mistakes: Where Do They Usually Start?
Hiring Mistakes: Where Do They Usually Start?
by Jacqueline Columbine
Posted in Biopharma, HealthTech, Life Science & Diagnostics, MedTech & Devices
Hiring the right talent is crucial to success. As a recruitment company specializing in life science and medical executive search, we’ve seen first-hand how hiring mistakes can derail even the most promising companies. But where do these mistakes typically start? Understanding the root causes can help organizations refine their hiring strategies and secure top talent more effectively.
Read more
January Biotech Insights: Key Discoveries 2025
January Biotech Insights: Key Discoveries 2025
by Katie Davis
Posted in Life Science & Diagnostics
Head-hunter Katie Davis is consistently keeping up to date with the latest news within the biotech industry, whether that be funding news, acquisitions, spin outs and expansions, legal updates, layoffs and restructuring, collaborations or general product updates. In this blog, we explore the latest updates throughout the month of January. You can subscribe to Katies biotech funding updates over on LinkedIn to keep up to date with the ever-growing biotech market.
Read more
IPO Momentum in Biotech: What Does it Mean for Companies and Talent in 2025?
IPO Momentum in Biotech: What Does it Mean for Companies and Talent in 2025?
by Katie Davis
Posted in Biopharma, Life Science & Diagnostics
Across the life sciences market, IPOs are more than just fundraising —they are indicators of investor confidence and market potential. After a slowdown in recent years, IPO activity is picking up pace again in 2025, particularly within biotech. In this blog, Katie Davis explores the latest trends.
Read more
Nail Your Next Job Interview
Nail Your Next Job Interview
by Jacqueline Columbine
Posted in Biopharma, HealthTech, Life Science & Diagnostics, MedTech & Devices
56% of full-time employees in the US want a new job in 2025, and 27% have already started searching. The beginning of a new year is a time for fresh opportunities and setting goals, but the interview process can often feel like the most daunting part of landing your dream job.
Read more
CASE STUDY: Building a European team for SeqOne Genomics
CASE STUDY: Building a European team for SeqOne Genomics
by Revna Comertpay
Posted in Case Studies, Life Science & Diagnostics
We have partnered with genomics startup SeqOne Genomics since 2021, building out their European teams. Recently, Revna Comertpay and team sourced five more crucial hires, all of which required specific industry expertise.
Read more
End of Year Hiring: The Key to Starting Strong in 2025
End of Year Hiring: The Key to Starting Strong in 2025
by Chris Pickles
Posted in Biopharma, HealthTech, Life Science & Diagnostics, MedTech & Devices
During December, many businesses put hiring on hold, opting to restart their recruitment efforts in the new year. While this may seem logical, it could mean missing out on a golden opportunity to build your team. December is an often-overlooked but highly strategic month to hire. 
Read more